共 57 条
[1]
Parks AL(2016)Anticoagulation in older adults with multimorbidity Clin Geriatr Med 32 331-346
[2]
Fang MC(2018)Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care BMJ 360 74-84
[3]
Kumar S(2017)Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study Am Heart J 185 955-962
[4]
de Lusignan S(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 104-132
[5]
McGovern A(2019)2019 AHA/ ACC/HRS focused update of the 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 74 123-131
[6]
Chamberlain AM(2019)Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: insights from the ARISTOTLE trial Am Heart J 208 315-329
[7]
Alonso A(2016)Multimorbidity in older adults with atrial fibrillation Clin Geriatr Med 32 329-336
[8]
Gersh BJ(2018)Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort Europace 20 3166-3184
[9]
Ruff CT(2021)Use of non-vitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and multimorbidity Adv Ther 38 e182870-339
[10]
Giugliano RP(2018)Assessment of outcomes of treatment with oral anticoagulants in patients with atrial fibrillation and multiple chronic conditions: a comparative effectiveness analysis JAMA Netw Open 1 e003725-3107